Recombinant polypeptides comprising single-domain antibodies targeting herv-k subtype hml-2
US-2025276015-A1 · Sep 4, 2025 · US
Retroviridae (F), e.g. leukemia viruses
Retroviridae (F), e.g. leukemia viruses · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/112 |
| Official title | Retroviridae (F), e.g. leukemia viruses |
| Display label | Retroviridae (F), e.g. leukemia viruses |
| Total patents | 39 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 5 |
| 2021 | 6 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Antibodies that bind interleukin-10 receptor-2 peptides, compositions, and methods of use thereof
US-12275783-B2 · Apr 15, 2025 · US
Antibodies having pan-antiviral activity and methods thereof
US-2025051425-A1 · Feb 13, 2025 · US
Viral clearance by low ph hold
US-2024384243-A1 · Nov 21, 2024 · US
Antigen binding molecules and methods of use
US-2024343820-A1 · Oct 17, 2024 · US
Viral clearance by low pH hold
US-12077782-B2 · Sep 3, 2024 · US
Endogenous retrovirus-k (ERVK) encodes an alternate envelope protein
US-12064407-B2 · Aug 20, 2024 · US
Methods for determining spatial and temporal gene expression dynamics in single cells
US-12060412-B2 · Aug 13, 2024 · US
Endogenous retrovirus-k (ervk) encodes an alternate envelope protein
US-2023064896-A1 · Mar 2, 2023 · US
Viral clearance by low ph hold
US-2021348131-A1 · Nov 11, 2021 · US
Growth differentiation factor 15 agonist compounds and methods of using the same
US-11104711-B2 · Aug 31, 2021 · US
Interleukin-10 receptor-2 peptides, antibodies, compositions, and methods of use thereof
US-2021221881-A1 · Jul 22, 2021 · US
Interleukin-10 receptor-2 peptides, antibodies, compositions, and methods of use thereof
US-10995139-B2 · May 4, 2021 · US
Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof
US-10981976-B2 · Apr 20, 2021 · US
Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis
US-10981977-B2 · Apr 20, 2021 · US
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
US-10723787-B2 · Jul 28, 2020 · US
IL2R common gamma chain antibodies
US-10696747-B2 · Jun 30, 2020 · US
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy
US-10662246-B2 · May 26, 2020 · US
Human Monoclonal Antibodies to Human Endogenous Retrovirus K Envelope (HERV-K) and Use Thereof
US-2020140527-A1 · May 7, 2020 · US
Human endogenous retroviral protein
US-2020102353-A1 · Apr 2, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/112?
- CPC C07K16/112 is the Cooperative Patent Classification code for “Retroviridae (F), e.g. leukemia viruses.”
- How many patents are filed under CPC C07K16/112 (Retroviridae (F), e.g. leukemia viruses)?
- Our database includes 39 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/112 growing?
- Publication counts under this code: 5 in 2024 vs 3 in 2025 (latest complete years).